A quantitative evaluation of active gelatinolytic sites in uterine endometrioid adenocarcinoma using film in situ zymography: Association of stronger gelatinolysis with myometrial invasion

Japanese Journal of Cancer Research

Volumn 93, Issue 5, 2002, Pages 516-522

  Zheng, Kefei ^a   Nagai, Yuichiro ^a   Kishimoto, Takashi ^a   Yamazawa, Koji ^a   Tate, Shinji ^b   Nemori, Ryoichi ^c   Hirai, Yasuo ^b   Sekiya, Souei ^a   Ishikura, Hiroshi ^a  

^a CHIBA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b CANCER INSTITUTE HOSPITAL   (Japan)

^c FUJIFILM CORPORATION   (Japan)

Author keywords

Autoexposure time; Endometrioid adenocarcinoma; In situ zymography; Myometrium; Uterus

Indexed keywords

CHELATING AGENT; GELATIN; GELATINASE; GELATINASE A; GELATINASE B; MATRIX METALLOPROTEINASE; COLLAGEN;

ADULT; AGED; ARTICLE; CANCER CELL; CANCER GRADING; CANCER INVASION; CANCER STAGING; CLINICAL ARTICLE; COLLAGEN DEGRADATION; CONTROLLED STUDY; ENDOMETRIOID CARCINOMA; ENZYME ACTIVITY; ENZYME REPRESSION; FEMALE; FILM; HUMAN; HUMAN TISSUE; IMMUNOREACTIVITY; METASTASIS; MYOMETRIUM; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; TIME; ZYMOGRAPHY; ADENOCARCINOMA; BIOSYNTHESIS; ENDOMETRIUM TUMOR; IMMUNOHISTOCHEMISTRY; METABOLISM; MIDDLE AGED; PATHOLOGY;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; CHELATING AGENTS; COLLAGEN; ENDOMETRIAL NEOPLASMS; FEMALE; GELATINASES; HUMANS; IMMUNOHISTOCHEMISTRY; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; MATRIX METALLOPROTEINASES; MIDDLE AGED; TIME FACTORS;

EID: 0036309731     PISSN: 09105050     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1349-7006.2002.tb01286.x     Document Type: Article

References (24)

1. Matrix metalloproteinases and their inhibitors in connective tissue remodeling
2. Matrix metalloproteinases and the development of cancer
3. The matrix-degrading metalloproteinases
4. Matrix-metalloproteinases: A review
5. Metalloproteinases and cancer invasion
6. Levels of matrix metalloproteinases in bladder cancer correlate with tumor grade and invasion
7. Matrix metalloproteinases and tissue inhibitors of metalloproteinases in human fetal testis and ovary
8. Expression of matrix metalloproteinases and their inhibitors correlates with invasion and metastasis in squamous cell carcinoma of the head and neck
9. Role of MMP-2 in alveolar epithelial cell repair after bleomycin administration in rabbits
10. Analyses of matrix metalloproteinases and their inhibitors in cyst fluid of serous ovarian tumors
11. Distinct expression patterns and levels of enzymatic activity of matrix metalloproteinases and their inhibitors in primary brain tumors
12. Clarification of the active gelatinolytic sites in human ovarian neoplasms using in situ zymography
13. Localization of gelatinolytic activity can be detected in breast cancer tissues by film in situ zymography
14. Expression of messenger RNAs for metalloproteinases 2 and 9, type IV collagen, and laminin in nonneoplastic and neoplastic endometrium
15. Expression of latent matrix metalloproteinase 9 (MMP-9) predicts survival in advanced ovarian cancer
16. Increased expression of matrix metalloproteinase-9 in nasal polyps
17. Angiogenesis extent and expression of matrix metalloproteinase-2 and -9 correlate with upgrading and myometrial invasion in endometrial carcinoma
18. Expression and localization of matrilysin, a matrix metalloproteinase, in human endometrium during the reproductive cycle
19. Patterns of matrix metalloproteinase expression in cycling endometrium imply differential functions and regulation by steroid hormones
20. Localization of MT1-MMP, TIMP-1, TIMP-2 and TIMP-3 messenger RNA in normal, hyperplastic, and neoplastic endometrium
21. Tissue inhibitors of metalloproteinases: Evolution, structure and function
22. Cyclic changes in the matrix metalloproteinases system in the ovary and uterus